APOE and early-onset autosomal dominant Alzheimer disease: Similarly, cognitively healthy preclinical adults (defined by APOE genotype or Alzheimer’s disease pathologies), as well as MCI and Alzheimer’s disease patients, also perform significantly worse in tests of feature binding, showing a marked decline in representational fidelity.18